Patents by Inventor Philippe Fernandes

Philippe Fernandes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Small molecule inhibitors of the JAK family of kinases
    Patent number: 11787807
    Abstract: 2-((1r,4r)-4-(imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)cyclohexyl)acetonitrile compounds, pharmaceutical compositions containing them, methods of making them, and methods of using them including methods for treating disease states, disorders, and conditions mediated by JAK.
    Type: Grant
    Filed: July 15, 2021
    Date of Patent: October 17, 2023
    Assignee: Janssen Pharmaceutica NV
    Inventors: Philippe Fernandes, Paul J. Krawczuk, Mark S. Tichenor
  • FORMS OF ATICAPRANT
    Publication number: 20230277499
    Abstract: The disclosure provides crystalline and amorphous forms of aticaprant. Also provided by the disclosure are pharmaceutical compositions comprising the amorphous or crystalline forms, methods of treating major depressive disorder using the amorphous or crystalline forms of aticaprant, amorphous or crystalline forms of aticaprant for use in the treatment of major depressive disorder in a human patient having anhedonia, uses of the amorphous or crystalline forms of aticaprant in the manufacture of a medicament for the treatment of major depressive disorder, and packages or pharmaceutical products comprising (i) amorphous or crystalline forms of aticaprant and (ii) instructions for treating major depressive disorder. In some aspects, the human patient treated as described herein has anhedonia.
    Type: Application
    Filed: March 6, 2023
    Publication date: September 7, 2023
    Inventors: Philippe Fernandes, Mark Schmidt, Vanina Popova, Adam Savitz, Rama Melkote, Wayne C. Drevets, Srihari Gopal, Darrel Pemberton, Chakradhar Lagishetty, Iva Kezic
  • Solid forms of Cerdulatinib
    Patent number: 11713309
    Abstract: Forms of cerdulatinib and salts or co-crystals thereof were prepared and characterized in the solid state. Also provided are processes of manufacture and methods of using the forms cerdulatinib and salts or co-crystals thereof.
    Type: Grant
    Filed: November 16, 2020
    Date of Patent: August 1, 2023
    Assignee: Alexion Pharmaceuticals, Inc.
    Inventors: Anjali Pandey, Julian Scott Northen, Philippe Fernandes, Ying Chen, Yuelie Lu, Sami Karaborni, Gus Kodersha
  • Solid forms of Cerdulatinib
    Patent number: 11661414
    Abstract: Forms of cerdulatinib and salts or co-crystals thereof were prepared and characterized in the solid state. Also provided are processes of manufacture and methods of using the forms cerdulatinib and salts or co-crystals thereof.
    Type: Grant
    Filed: November 16, 2020
    Date of Patent: May 30, 2023
    Assignee: Alexion Pharmaceuticals, Inc.
    Inventors: Anjali Pandey, Julian Scott Northen, Philippe Fernandes, Ying Chen, Yuelie Lu, Sami Karaborni, Gus Kodersha
  • Aircraft undercarriage fitted with visual warning means for signaling an angular overstroke of a steerable bottom portion of the undercarriage
    Patent number: 11407524
    Abstract: An aircraft undercarriage comprising a top portion (2) secured to the aircraft and a steerable bottom portion (3) carrying wheels and suitable for being steered by a steering control system (4) fitted to the undercarriage or else by an external towing device, the undercarriage being fitted with visual warning means (9) for indicating an angular overstroke. The visual warning means comprising at least one visual indicator (14) mounted to move between a retracted position that is invisible and an extended position that is visible. An aircraft provided with an undercarriage.
    Type: Grant
    Filed: June 18, 2020
    Date of Patent: August 9, 2022
    Assignee: SAFRAN LANDING SYSTEMS
    Inventors: Philippe Fernandes, Marc Farcy, Christophe Clement
  • CRYSTAL FORMS OF BETA-NICOTINAMIDE MONONUCLEOTIDE
    Publication number: 20220098229
    Abstract: The invention relates to crystalline forms of a ?-nicotinamide mononucleotide, methods of their preparation, and related pharmaceutical preparations thereof. The invention also relates to preparations suitable for nutraceutical, veterinary, and agriculturally-relevant uses.
    Type: Application
    Filed: June 9, 2021
    Publication date: March 31, 2022
    Inventors: David J. Livingston, Andrew Carr, Philippe Fernandes
  • SMALL MOLECULE INHIBITORS OF THE JAK FAMILY OF KINASES
    Publication number: 20210340144
    Abstract: 2-((1r,4r)-4-(imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)cyclohexyl)acetonitrile compounds, pharmaceutical compositions containing them, methods of making them, and methods of using them including methods for treating disease states, disorders, and conditions mediated by JAK.
    Type: Application
    Filed: July 15, 2021
    Publication date: November 4, 2021
    Inventors: Philippe FERNANDES, Paul J. Krawczuk, Mark S. Tichenor
  • Small molecule inhibitors of the JAK family of kinases
    Patent number: 11066406
    Abstract: 2-((1r,4r)-4-(imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)cyclohexyl)acetonitrile compounds, pharmaceutical compositions containing them, methods of making them, and methods of using them including methods for treating disease states, disorders, and conditions mediated by JAK.
    Type: Grant
    Filed: January 29, 2020
    Date of Patent: July 20, 2021
    Assignee: Janssen Pharmaceutica NV
    Inventors: Philippe Fernandes, Paul J. Krawczuk, Mark S. Tichenor
  • Crystal forms of ?-nicotinamide mononucleotide
    Patent number: 11059847
    Abstract: The invention relates to crystalline forms of a ?-nicotinamide mononucleotide, methods of their preparation, and related pharmaceutical preparations thereof. The invention also relates to preparations suitable for nutraceutical, veterinary, and agriculturally-relevant uses.
    Type: Grant
    Filed: June 27, 2019
    Date of Patent: July 13, 2021
    Assignee: Metro International Biotech, LLC
    Inventors: David J. Livingston, Andrew Carr, Philippe Fernandes
  • SOLID FORMS OF CERDULATINIB
    Publication number: 20210130330
    Abstract: Forms of cerdulatinib and salts or co-crystals thereof were prepared and characterized in the solid state. Also provided are processes of manufacture and methods of using the forms cerdulatinib and salts or co-crystals thereof.
    Type: Application
    Filed: November 16, 2020
    Publication date: May 6, 2021
    Inventors: Anjali Pandey, Julian Scott Northen, Philippe Fernandes, Ying Chen, Yuelie Lu, Sami Karaborni, Gus Kodersha
  • AIRCRAFT UNDERCARRIAGE FITTED WITH VISUAL WARNING MEANS FOR SIGNALING AN ANGULAR OVERSTROKE OF A STEERABLE BOTTOM PORTION OF THE UNDERCARRIAGE
    Publication number: 20200398996
    Abstract: An aircraft undercarriage comprising a top portion (2) secured to the aircraft and a steerable bottom portion (3) carrying wheels and suitable for being steered by a steering control system (4) fitted to the undercarriage or else by an external towing device, the undercarriage being fitted with visual warning means (9) for indicating an angular overstroke. The visual warning means comprising at least one visual indicator (14) mounted to move between a retracted position that is invisible and an extended position that is visible. An aircraft provided with an undercarriage.
    Type: Application
    Filed: June 18, 2020
    Publication date: December 24, 2020
    Applicant: SAFRAN LANDING SYSTEMS
    Inventors: Philippe FERNANDES, Marc FARCY, Christophe CLEMENT
  • Solid forms of cerdulatinib
    Patent number: 10865198
    Abstract: Forms of cerdulatinib and salts or co-crystals thereof were prepared and characterized in the solid state. Also provided are processes of manufacture and methods of using the forms cerdulatinib and salts or co-crystals thereof.
    Type: Grant
    Filed: May 3, 2019
    Date of Patent: December 15, 2020
    Assignee: Alexion Pharmaceuticals, Inc.
    Inventors: Anjali Pandey, Julian Scott Northen, Philippe Fernandes, Ying Chen, Yuelie Lu, Sami Karaborni, Gus Kodersha
  • Small Molecule Inhibitors of the JAK Family of Kinases
    Publication number: 20200165250
    Abstract: 2-((1r,4r)-4-(imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)cyclohexyl)acetonitrile compounds, pharmaceutical compositions containing them, methods of making them, and methods of using them including methods for treating disease states, disorders, and conditions mediated by JAK.
    Type: Application
    Filed: January 29, 2020
    Publication date: May 28, 2020
    Inventors: Philippe Fernandes, Paul J. Krawczuk, Mark S. Tichenor
  • Crystal Forms of ß-Nicotinamide Mononucleotide
    Publication number: 20200157136
    Abstract: The invention relates to crystalline forms of a ?-nicotinamide mononucleotide, methods of their preparation, and related pharmaceutical preparations thereof. The invention also relates to preparations suitable for nutraceutical, veterinary, and agriculturally-relevant uses.
    Type: Application
    Filed: June 27, 2019
    Publication date: May 21, 2020
    Inventors: David J. Livingston, Andrew Carr, Philippe Fernandes
  • SOLID FORMS OF CERDULATINIB
    Publication number: 20200031804
    Abstract: Forms of cerdulatinib and salts or co-crystals thereof were prepared and characterized in the solid state. Also provided are processes of manufacture and methods of using the forms cerdulatinib and salts or co-crystals thereof.
    Type: Application
    Filed: May 3, 2019
    Publication date: January 30, 2020
    Inventors: Anjali Pandey, Julian Scott Northen, Philippe Fernandes, Ying Chen, Yuelie Lu, Sami Karaborni, Gus Kodersha
  • Small Molecule Inhibitors of the JAK Family of Kinases
    Publication number: 20200017498
    Abstract: 2-((1r,4r)-4-(imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)cyclohexyl)acetonitrile compounds, pharmaceutical compositions containing them, methods of making them, and methods of using them including methods for treating disease states, disorders, and conditions mediated by JAK.
    Type: Application
    Filed: September 24, 2019
    Publication date: January 16, 2020
    Inventors: Philippe Fernandes, Paul J. Krawczuk, Mark S. Tichenor
  • Crystal forms of beta-nicotinamide mononucleotide
    Patent number: 10392416
    Abstract: The invention relates to crystalline forms of a ?-nicotinamide mononucleotide, methods of their preparation, and related pharmaceutical preparations thereof. The invention also relates to preparations suitable for nutraceutical, veterinary, and agriculturally-relevant uses.
    Type: Grant
    Filed: March 28, 2019
    Date of Patent: August 27, 2019
    Assignee: Metro International Biotech, LLC
    Inventors: David J. Livingston, Andrew Carr, Philippe Fernandes
  • Crystal forms of ?-nicotinamide mononucleotide
    Patent number: 10392415
    Abstract: The invention relates to crystalline forms of a ?-nicotinamide mononucleotide, methods of their preparation, and related pharmaceutical preparations thereof. The invention also relates to preparations suitable for nutraceutical, veterinary, and agriculturally-relevant uses.
    Type: Grant
    Filed: September 30, 2016
    Date of Patent: August 27, 2019
    Assignee: Metro International Biotech, LLC
    Inventors: David J. Livingston, Andrew Carr, Philippe Fernandes
  • Crystal Forms of Beta-Nicotinamide Mononucleotide
    Publication number: 20190225641
    Abstract: The invention relates to crystalline forms of a ?-nicotinamide mononucleotide, methods of their preparation, and related pharmaceutical preparations thereof. The invention also relates to preparations suitable for nutraceutical, veterinary, and agriculturally-relevant uses.
    Type: Application
    Filed: March 28, 2019
    Publication date: July 25, 2019
    Inventors: Andrew Carr, Philippe Fernandes, David J. Livingston
  • CRYSTAL FORMS OF BETA-NICOTINAMIDE MONONUCLEOTIDE
    Publication number: 20190085009
    Abstract: The invention relates to crystalline forms of a ?-nicotinamide mononucleotide, methods of their preparation, and related pharmaceutical preparations thereof. The invention also relates to preparations suitable for nutraceutical, veterinary, and agriculturally-relevant uses.
    Type: Application
    Filed: September 17, 2018
    Publication date: March 21, 2019
    Inventors: Andrew Carr, Philippe Fernandes, David J. Livingston